Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:endometrial adenocarcinoma incidence/prevalence measurement
go back to main search page
Accession:CMO:0001789 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display endometrial adenocarcinomas at a point in time or develop endometrial adenocarcinomas within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. An endometrial adenocarcinoma is an abnormal and malignant growth of the epithelial cells of the mucous membrane lining the uterus that results from uncontrolled, progressive multiplication of cells, serves no physiological function, and forms or appears to form glandular structures.
Synonyms:related_synonym: endometrioid carcinoma incidence/prevalence measurement
 xref: MESH:D018269



show annotations for term's descendants           Sort by:

Term paths to the root